| Quarter | Score |
|---|---|
| 2024-Q1 | 46.1 |
| 2024-Q2 | 45.1 |
| 2024-Q3 | 53.6 |
| 2024-Q4 | 32.8 |
| 2025-Q1 | 32.7 |
| 2025-Q2 | 34.0 |
| 2025-Q3 | 58.0 |
| 2025-Q4 | 32.4 |
| 2026-Q1 | 32.3 |
| 2026-Q2 | 57.9 |
Solid consensus with smart money net adding at reasonable prices
Trading 23.6% below funds' estimated purchase price
2 of 18 tracked funds hold ALVO. Avg conviction: 0.0%. Net holding. First tracked at $7.96 (current -23.6% vs tracked).
Oaktree Capital has 0.0% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 0.0% | Reduce |
| Citadel Advisors | 0.0% | New Buy |